Clinical Trial

Long-term Outcomes After Laparoscopic Subtotal and Total Hysterectomy

Study acronym: LAST-1
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 2, 2022 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Hysterectomy is one of the most commonly performed gynecologic surgeries in the USA. It is used for many benign conditions such as leiomyoma and abnormal uterine bleeding. Surgery may involve the removal of the cervix (total hysterectomy, TH) or its preservation (supracervical or subtotal hysterectomy, SH). Whether TH or SH is the best procedure for benign conditions is a matter of debate. Considering the lack of evidence, this study aims to evaluate long-term sexual dysfunctions, urinary dysfunctions and pelvic organ prolapse in women who underwent laparoscopic subtotal versus total hysterectomy for benign conditions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-06-12.
Trial Details
NCT Number NCT05421156
Lead Sponsor University of Palermo
Conditions Hysterectomy
Enrollment 100 participants
Start Date 2024-07
Primary Completion 2026-07 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2022-11-02